T
Thomas F. Lüscher
Researcher at University of Zurich
Publications - 1613
Citations - 88517
Thomas F. Lüscher is an academic researcher from University of Zurich. The author has contributed to research in topics: Endothelium & Myocardial infarction. The author has an hindex of 134, co-authored 1560 publications receiving 79034 citations. Previous affiliations of Thomas F. Lüscher include University of Texas Southwestern Medical Center & Durham University.
Papers
More filters
Journal ArticleDOI
Aging, serum estradiol levels, and pregnancy differentially affect vascular reactivity of the rat uterine artery.
Edward Wight,Christoph F. Küng,Pierre Moreau,Hiroyuki Takase,N. A. Bersinger,Thomas F. Lüscher +5 more
TL;DR: Vascular contractility is impaired in the uterine artery of the aged rat as evidenced by reduced responses to KCl, whereas responses to receptor-operated agonists remain unchanged.
Journal ArticleDOI
Interactions between endothelin and endothelium-derived relaxing factor
TL;DR: This chapter focuses on the interactions of endothelin-1, endothelium-derived nitric oxide, and prostacyclin at the levels of the endothelia and the vascular smooth muscle cell.
Journal ArticleDOI
A Comparative Study Between 100mg Atenolol and 20mg Pindolol Slow-Release in Essential Hypertension
Greminger P,H. Vetter,Boerlin Hj,J. Havelka,Baumgart P,P. Walger,Thomas F. Lüscher,W. Siegenthaler,W. Vetter +8 more
TL;DR: It is demonstrated that 100mg atenolol produces a more pronounced diastolic pressure reduction than 20mg pindolol SR and a significant percentage of patients responded to atenoliol after being unresponsive to pINDolol.
Journal ArticleDOI
N-terminal pro-B-type natriuretic peptide-ratio predicts mortality after transcatheter aortic valve replacement
Barbara E. Stähli,Catherine Gebhard,Lanja Saleh,Volkmar Falk,Ulf Landmesser,Fabian Nietlispach,Francesco Maisano,Thomas F. Lüscher,Willibald Maier,Ronald K. Binder +9 more
TL;DR: Elevated NT‐proBNP‐ratio was associated with increased short‐ and long‐term mortality after TAVR, and independently predicted all‐cause mortality.
Journal ArticleDOI
Vascular effects of newer cardiovascular drugs: focus on nebivolol and ACE-inhibitors.
TL;DR: In summary, cardiovascular drugs have important effects on the vessel wall, which may be clinically relevant for the prevention and treatment of cardiovascular disease.